CRISPR Therapeutics Aktie

Kaufen

Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

47,00 EUR -1,00 EUR -2,08 %

25.02.2026

BMN

55,19 USD -0,02 USD -0,04 %

nachbörslich00:47:00

BTT

CRISPR Therapeutics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Bei einem anderen Broker handeln

Smartphone

Marktkap.4,39 Mrd. EUR

Div. Rendite0,00%

WKNA2AT0Z

ISINCH0334081137

SymbolCRSP

CRISPR Therapeutics Aktien News

Sortieren:Datum Meistgelesen

20.02.26MotleyFoolIs CRISPR Therapeutics Stock Going to $0, or Will the Hype Pay Off?

20.02.26wikifolioSmall Cap statt Big Tech - mit Nebenwerten auf der Überholspur

18.02.26MotleyFoolShould You Buy Shares of CRISPR Therapeutics in February?

WerbungCRISPR Therapeutics-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

17.02.26ZacksCRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

16.02.26wikifolioDie heißesten Aktien der letzten Woche

14.02.26finanzen.netCRISPR Therapeutics: Quartalsergebnisse zum jüngsten Jahresviertel

13.02.26MotleyFoolWhy CRISPR Therapeutics Stock Is Up Today (Despite Its Q4 Earnings Miss)

13.02.26BenzingaCRISPR Therapeutics Spotlights Momentum For Lead Gene Therapy As Adoption Widens

13.02.26ZacksCRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Lags Revenue Estimates

12.02.26BenzingaCRISPR Therapeutics Earnings Report: Q4 Overview

06.02.26ZacksCRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

03.02.26ZacksCRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: Should You Buy?

02.02.26ZacksCRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing

29.01.26BenzingaWhat Does the Market Think About CRISPR Therapeutics AG?

26.01.26ZacksCRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why

26.01.26ZacksCRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

24.01.26ZacksCRISPR Therapeutics AG (CRSP) Stock Declines While Market Improves: Some Information for Investors

15.01.26ZacksCRISPR Therapeutics AG (CRSP) Stock Declines While Market Improves: Some Information for Investors

13.01.26BenzingaWhat's Driving the Market Sentiment Around CRISPR Therapeutics AG?

13.01.26ZacksInvestors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know

12.01.26ZacksCRISPR Therapeutics (CRSP) Is Considered a Good Investment by Brokers: Is That True?

09.01.26ZacksCRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

06.01.26ZacksCRISPR Therapeutics AG (CRSP) Laps the Stock Market: Here's Why

30.12.25ZacksCRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know

30.12.25ZacksHere is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock

24.12.25MotleyFoolIs CRISPR Therapeutics Stock Yesterday's News?

23.12.25ZacksCRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know

22.12.25BenzingaCRISPR Therapeutics CRISPR Therapy Shows 90% Response Rate In Aggressive Blood Cancer

19.12.25ZacksIs Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now?

19.12.25MotleyFoolIs CRISPR Therapeutics a Buy, Sell, or Hold in 2026?

18.12.25BenzingaIs the Market Bullish or Bearish on CRISPR Therapeutics AG?

17.12.25ZacksCRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know

10.12.25ZacksWhy Is CRISPR Therapeutics (CRSP) Up 3.3% Since Last Earnings Report?

09.12.25PR NewswireBeyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions

09.12.25PR NewswireBeyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions

08.12.25ZacksCRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

25.11.25ZacksCRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

14.11.25ZacksCRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

12.11.25MotleyFoolARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried?

12.11.25finanzen.netCRISPR Therapeutics präsentierte das Zahlenwerk zum abgelaufenen Jahresviertel

CRISPR Therapeutics News

CRISPR Therapeutics News: auf dieser Seite finden Sie alle CRISPR Therapeutics News und Nachrichten zur CRISPR Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch CRISPR Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um CRISPR Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.